Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0550 (0.21%) ($7.0550 - $7.0550) on Wed. Jul. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 17 | Latest Price | $7.0550(0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(36%) VCIT(27%) BND(26%) LQD(24%) SHY(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.42% in a week (0% probabilities). XLRE(-29%) XLP(-23%) TBT(-21%) SPLV(-20%) DIA(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.44(-233.81%) | Resistance Level | $7.58 | 5 Day Moving Average | $7.04(0.21%) | 10 Day Moving Average | $7.05(0.07%) | 20 Day Moving Average | $7.58(-6.93%) | To recent high | -20.3% | To recent low | 1.7% | Market Cap | $1.245b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |